to identify, implement and validate innovative community centered approaches to cancer clinical trials education.

• Only 3 to 5 percent of all adult cancer patients participate in clinical trials.
  
• Minorities with cancer are less likely to be offered participation in a clinical trial.
  
• There are many barriers that limit access to clinical trials at the local community level.
  
• “There must be enhanced efforts at minority patient recruitment and retention to (cancer) clinical trials...success will require sustained, aggressive action and new partnerships between policymakers, healthcare professionals, professional societies and underserved communities.”
  
Click here for reference  
• “(Equal) access to clinical trials is less a matter of scientific necessity than of social justice.”
  
Click here for reference